Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPL | P40238 | 9/20 | 0.49 |
| ▸ | NT5E | P21589 | 2/20 | 0.44 |
| ▸ | AURKA | O14965 | 1/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CTRC | Q99895 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.40 |
| ▸ | RECQL | P46063 | 2/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29431679 | 1.00 | MPL (0.49) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL1673092 | 0.98 | MPL (0.47) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL592364 | 0.98 | MPL (0.47) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL217202 | 0.98 | MPL (0.47) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL31344266 | 0.98 | MPL (0.47) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL2776938 | 0.98 | MPL (0.47) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL29110854 | 0.98 | MPL (0.47) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL4957991 | 0.96 | MPL (0.49) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL29440243 | 0.96 | MPL (0.49) | MPLNT5EAURKAAURKBCYP1A2 | |
| SCHEMBL590946 | 0.94 | MPL (0.47) | MPLNT5EAURKAAURKBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1970 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260033757-A1 | TRANSCUTANEOUS CO2 SENSOR AND USES THEREOF | BIOSENCY (FR) | 2026-02-05 | — | — | US | claimed |
| EP-3865853-B1 | VALIDATION OF SENSOR CALIBRATION | SCILOGICA CORP (US) | 2026-01-28 | — | — | EP | claimed |
| US-12528916-B2 | Transmembrane pH-gradient polymersomes | ETH ZURICH (CH) | 2026-01-20 | — | — | US | claimed |
| US-20250207175-A1 | METHOD FOR DETECTING CONTAMINATING CARBOXYLESTERASE ACTIVITY | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-06-26 | — | — | US | claimed |
| EP-4490518-A1 | METHOD FOR DETECTING CONTAMINATING CARBOXYLESTERASE ACTIVITY | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-01-15 | — | — | EP | claimed |
| CN-117030667-B | Multifunctional optical sensor and preparation method thereof | 北京邮电大学 | 2024-07-16 | — | — | CN | claimed |
| US-11999829-B2 | Method of making a polymersome | ETH ZURICH (CH) | 2024-06-04 | — | — | US | claimed |
| WO-2024101447-A1 | DIAGNOSIS METHOD, DIAGNOSIS DEVICE, AND ANTIBODY REGENERATION METHOD | 国立大学法人信州大学 | 2024-05-16 | — | — | WO | claimed |
| US-11892401-B2 | Boronic acid appended naphthyl-pyridinium fluorescent saccharide sensors for early detection of gastrointestinal diseases | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-02-06 | — | — | US | claimed |
| WO-2023242454-A1 | HYBRID MATERIAL FOR DETECTING ACID AND BASE VAPOURS | UNIVERSIDAD DE CASTILLA LA MANCHA (ES) | 2023-12-21 | — | — | WO | claimed |
| US-4833091-A | DETECTION OF CARBON DIOXIDE IN WATER WITH FLUORESCENT DYES | SHILEY INCORPORATED (US) | 1989-05-23 | — | — | US | claimed |
| EP-0283116-A2 | Sensor system | SHILEY INCORPORATED (US) | 1988-09-21 | — | — | EP | claimed |
| EP-0208697-A1 | PLASMA SUBSTITUTE | Battelle-Institut e.V. (DE) | 1987-01-21 | — | — | EP | claimed |
| WO-1986004240-A1 | PLASMA SUBSTITUTE | BATTELLE - INSTITUT E.V. (DE) | 1986-07-31 | — | — | WO | claimed |
| EP-0087060-B1 | FLUORESCENT MAKE-UP | A.W. Faber - Castell GmbH & Co. (DE) | 1986-07-16 | — | — | EP | claimed |
| US-4548907-A | Fluorescent fluid determination method and apparatus | ALLIED CORPORATION (US) | 1985-10-22 | — | — | US | claimed |
| EP-0034261-B1 | AQUEOUS CHEMILUMINESCENT SYSTEMS | AMERICAN CYANAMID COMPANY (US) | 1985-05-22 | — | — | EP | claimed |
| EP-0137157-A2 | Fluid analysis technology using fluorescence type sensors | Fisher Scientific Company (US) | 1985-04-17 | — | — | EP | claimed |
| US-4338213-A | Aqueous chemiluminescent systems | AMERICAN CYANAMID COMPANY (US) | 1982-07-06 | — | — | US | claimed |
| EP-0034261-A2 | Aqueous chemiluminescent systems | AMERICAN CYANAMID COMPANY (US) | 1981-08-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11892401-B2 | Boronic acid appended naphthyl-pyridinium fluorescent saccharide sensors for early detection of gastrointestinal diseases | SI, FABP2, FABP6 | MPL 2848/4885NT5E 24/4885AURKA 3922/4885 |
| US-20260033757-A1 | TRANSCUTANEOUS CO2 SENSOR AND USES THEREOF | CA2, TMCO1, SCO2 | MPL 4041/4885NT5E 2865/4885AURKA 2251/4885 |
| US-12528916-B2 | Transmembrane pH-gradient polymersomes | AQP4, ABCB11, SLC6A6 | MPL 4513/4885NT5E 2104/4885AURKA 2146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.